This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

District Court Says Inmate's Claim Against Prison Operators May Proceed

LOS ANGELES, Feb. 22, 2013 /PRNewswire/ -- Asserting that their inmate-client, Gregory Edison, was negligently exposed to a terminal and deadly form of Valley Fever, Los Angeles-based attorneys, Jason Feldman and Ian Wallach, prevailed in court on Friday, February 22, 2013, when the court held that the case of Edison v. GEO Group, Inc. et a l. (EDCA 1:12-cv-02026) could proceed.

The case before the United States District Court for the Eastern District of California, brought by an inmate housed at the Taft Correctional Facility in Taft, California, alleges that the subcontractors who operated the prison, The GEO Group, Inc. ("GEO") and Management and Training Corporation ("MTC"), failed to protect Mr. Edison from acquiring the terminal form of coccidiodomycosis (aka "Valley Fever").  

GEO and MTC moved to dismiss the case--asserting that the Plaintiff failed to exhaust the administrative remedy filing requirements normally asserted by Governmental entities.  Feldman and Wallach countered that such requirements do not apply to tort claims against private entities.

United States Senior District Judge Anthony W. Ishii upheld the findings of Magistrate Judge Jennifer L. Thurston, who had explained that there was no statutory authority supporting Defendants' argument that they were permitted to impose an administrative remedy that must be exhausted before an inmate may file a complaint raising state tort claims. 

The Defendant corporations cited Wright v. State of California , 122 Cal.App.4th 659 (Cal.Ct.App. 2004), as authority for the proposition that an inmate raising a state-law claim must exhaust administrative remedies before suing them.  The Court disagreed, by stating "Neither GEO nor MTC are administrative tribunals. Thus, there is no other tribunal involved whose jurisdiction is an impediment to this Court's authority. Likewise, the instant matter does not concern remedies provided by an administrative agency, but instead, a remedial scheme imposed by private corporations." The Court further stated "There are statutorily-mandated procedures in place for tort claims (28 CFR part 543, subpart C) . . .. Coupled with 28 CFR § 542.10's explicit instruction that '…the Bureau will refer the inmate to the appropriate statutorily-mandated procedures,' there can be no serious argument that tort claims brought against the [Bureau of Prisons] must be pursued according to the four-part process as a prerequisite to filing suit."   The ruling also concluded its ruling remarks, with "Therefore, because 28 CFR § 542.10 does not require a federal prisoner placed in a federal prison to exhaust a tort claim through the four-part administrative remedy program, there is no legal footing for the proposition that a federal prisoner placed in a non-federal facility, must." 

"This is a great win for inmates whose terminal illnesses could have been prevented," said attorney Wallach, "All these prisoners want is their day in court. Wallach went on to say, "These rulings have paved the way for that possibility."    

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 0.00%
FB $118.57 0.00%
GOOG $698.21 0.00%
TSLA $241.80 0.00%
YHOO $36.53 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs